Taaleri Bioindustry
Taaleri Bioindustry, founded in 2021 and based in Helsinki, Finland, focuses on developing and investing in industrial-scale plants that promote the global bioeconomy. The firm aims to invest in disruptive technologies within the bioindustry sector across Europe, particularly in Denmark, Finland, Norway, and Sweden. Its investment strategy is executed through Taaleri Bioindustry Fund I, a growth expansion fund established in 2022, which targets investments ranging from EUR 10 million to EUR 25 million in 5 to 7 companies. The fund prioritizes sectors such as agricultural chemicals, industrial chemicals, specialty chemicals, packaging, forestry processing, textiles, and construction. Additionally, Taaleri Bioindustry emphasizes resource-efficient and sustainable materials, aligning its investment approach with impact objectives related to climate change.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.